LDART for Alcoholism
(LDART Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests a new digital tool called Let's Do Addiction Recovery Together! (LDART) to help people reduce alcohol intake. Researchers aim to determine if this tool is more helpful and user-friendly than simply providing a list of resources. The study seeks participants in Connecticut who have recently experienced several heavy drinking days and wish to reduce their alcohol consumption. Participants will need a smartphone with internet access.
As an unphased trial, this study offers a unique opportunity to contribute to the development of innovative digital health solutions.
Do I have to stop taking my current medications for the LDART trial?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What prior data suggests that this digital intervention is safe for adults with alcohol use disorder?
Research has shown that LDART, a digital tool for individuals with alcohol use disorder, is being tested for safety and effectiveness. In an earlier study, adults who drank heavily used LDART every night. The study aimed to determine if participants would use the tool and how it might help them reduce alcohol consumption.
The study found no serious side effects, indicating that LDART is safe to use. As a digital tool, LDART does not have the same side effects as medications, making it a promising option for those seeking to reduce alcohol use without additional medications.
Overall, while more research is needed to fully understand its effects, current data shows no major safety concerns with using LDART.12345Why are researchers excited about this trial?
LDART is unique because it leverages digital therapy to help treat alcoholism, offering a potentially more accessible and convenient option than traditional face-to-face counseling or medication. Researchers are excited about this treatment because it provides 24/7 access to therapeutic resources, which can empower individuals to manage their condition in real-time, enhancing engagement and adherence to treatment. Unlike standard options like disulfiram or naltrexone, which involve medication, LDART focuses on behavioral change through digital interaction, potentially reducing the need for medical supervision and minimizing side effects.
What evidence suggests that LDART is effective for alcohol use disorder?
Research on digital tools for assisting individuals with alcohol use disorder is still developing. LDART, which participants in this trial may receive, is one such tool designed to support recovery. Although specific data on LDART is not yet available, digital tools in general have shown promise in maintaining engagement and support during recovery. Studies suggest that community and emotional support effectively manage alcohol use disorder. These methods often focus on connecting individuals with helpful resources and support systems, aiding in reducing alcohol consumption. LDART's digital format may facilitate access to help and maintain connections with supportive networks.678910
Who Is on the Research Team?
Li Yan McCurdy, PhD
Principal Investigator
Yale University
Are You a Good Fit for This Trial?
This trial is for adults in Connecticut with alcohol use disorder who've had heavy drinking days recently and want to cut down or quit. They must have a smartphone, internet access, and score high on specific AUD tests. People can't join if they can't consent, don't speak English, are vulnerable individuals, or can't complete the study soon.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive access to the LDART digital intervention for 28 days
Follow-up
Participants are monitored for changes in recovery group engagement and drinking behavior
What Are the Treatments Tested in This Trial?
Interventions
- LDART
Find a Clinic Near You
Who Is Running the Clinical Trial?
Yale University
Lead Sponsor
National Institute on Drug Abuse (NIDA)
Collaborator